A Lagos weight loss account relays the CBS report and notes retatrutide still has no FDA approval for weight loss. The deaths are only possibly linked.
Recap by typeshit. Post by @getslimlagos on Instagram.
Bikman argues the facial change reflects rapid weight loss in general and suggests using the drug as a short-term aid for carb cravings. His view, not settled fact.
A clip from CNN's Body Language where two doctors point to common missteps they say lead to side effects on GLP-1 drugs. The full episode is on CNN.
An NYU obesity doctor outlines what people considering Ozempic or similar drugs should watch for. It is a general explainer for anyone weighing the shots.
15:57
A video on Chinese supply behind the peptide trend and the open question of what is actually in the vials people buy.
Exposures nearly doubled from 460 the quarter before, and the FDA got two death reports it hasn't verified. Lilly says it has referred over 200 sellers to regulators.
The 80-week Lancet study enrolled 1,152 adults. Placebo lost 5.1%, and nearly half on the 12 mg dose lost at least 20%. The drug is still investigational.
Loading…